表紙
市場調查報告書
商品編碼
1028951

免疫抑制劑的全球市場:COVID-19的成長及變化預測 (∼2030年)

Immunosuppressants Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球免疫抑制劑的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,醫藥品分類·適應症·通路·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,未來展望等資料。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場規模·成長預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各醫藥品分類
    • 皮質類固醇
    • 單株抗體(mAbs)
    • 鈣調磷酸酶抑製劑
    • mTOR抑制劑
    • 抗增生劑
    • 其他
  • 各適應症
    • 器官移植
    • 自體免疫疾病
    • 非自體免疫性發炎性疾病
  • 各銷售管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各醫藥品分類
  • 市場分析·預測:各適應症

第9章 中國市場分析·預測

第10章 印度市場分析·預測

第11章 日本市場分析·預測

第12章 澳洲市場分析·預測

第13章 印尼市場分析·預測

第14章 韓國市場分析·預測

第15章 西歐市場分析·預測

第16章 英國市場分析·預測

第17章 德國市場分析·預測

第18章 法國市場分析·預測

第19章 東歐市場分析·預測

第20章 俄羅斯市場分析·預測

第21章 北美市場分析·預測

第22章 美國市場分析·預測

第23章 南美市場分析·預測

第24章 巴西市場分析·預測

第25章 中東市場分析·預測

第26章 非洲市場分析·預測

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • Astellas Pharma
    • GlaxoSmithKline
    • Bristol Myers Squibb
    • Johnson & Johnson
    • Intas Pharmaceuticals Ltd.

第28章 開發平台分析

第28章 主要M&A

第29章 未來展望·潛在性分析

第30章 附錄

目錄
Product Code: h976

Immunosuppressants Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global immunosuppressants market.

This report focuses on immunosuppressants market which is experiencing strong growth. The report gives a guide to the immunosuppressants market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the immunosuppressants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Immunosuppressants market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider immunosuppressants market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The immunosuppressants market section of the report gives context. It compares the immunosuppressants market with other segments of the immunosuppressants market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, immunosuppressants indicators comparison.

Scope

Markets Covered:

1) By Drug Class: Corticosteroids; Monoclonal Antibodies (mAbs); Calcineurin Inhibitors; mTOR Inhibitors; Anti-Proliferative Agents; Others

2) By Indication: Organ Transplantation; Autoimmune Disorders; Non-Autoimmune Inflammatory Diseases

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Astellas Pharma; GlaxoSmithKline; Bristol Myers Squibb; Johnson & Johnson; Intas Pharmaceuticals Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Immuno Suppressive Drugs Market Characteristics

3. Immuno Suppressive Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Immuno Suppressive Drugs

5. Immuno Suppressive Drugs Market Size And Growth

  • 5.1. Global Immuno Suppressive Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Immuno Suppressive Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Immuno Suppressive Drugs Market Segmentation

  • 6.1. Global Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Corticosteroids
  • Monoclonal Antibodies (mAbs)
  • Calcineurin Inhibitors
  • mTOR Inhibitors
  • Anti-Proliferative Agents
  • Others
  • 6.2. Global Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Organ Transplantation
  • Autoimmune Disorders
  • Non-Autoimmune Inflammatory Diseases
  • 6.3. Global Immuno Suppressive Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

7. Immuno Suppressive Drugs Market Regional And Country Analysis

  • 7.1. Global Immuno Suppressive Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Immuno Suppressive Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Immuno Suppressive Drugs Market

  • 8.1. Asia-Pacific Immuno Suppressive Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Immuno Suppressive Drugs Market

  • 9.1. China Immuno Suppressive Drugs Market Overview
  • 9.2. China Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Immuno Suppressive Drugs Market

  • 10.1. India Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Immuno Suppressive Drugs Market

  • 11.1. Japan Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Immuno Suppressive Drugs Market

  • 12.1. Australia Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Immuno Suppressive Drugs Market

  • 13.1. Indonesia Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Immuno Suppressive Drugs Market

  • 14.1. South Korea Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Immuno Suppressive Drugs Market

  • 15.1. Western Europe Immuno Suppressive Drugs Market Overview
  • 15.2. Western Europe Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Immuno Suppressive Drugs Market

  • 16.1. UK Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Immuno Suppressive Drugs Market

  • 17.1. Germany Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Immuno Suppressive Drugs Market

  • 18.4. France Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Immuno Suppressive Drugs Market

  • 19.1. Eastern Europe Immuno Suppressive Drugs Market Overview
  • 19.2. Eastern Europe Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Immuno Suppressive Drugs Market

  • 20.1. Russia Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Immuno Suppressive Drugs Market

  • 21.1. North America Immuno Suppressive Drugs Market Overview
  • 21.2. North America Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Immuno Suppressive Drugs Market

  • 22.1. USA Immuno Suppressive Drugs Market Overview
  • 22.2. USA Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Immuno Suppressive Drugs Market

  • 23.1. South America Immuno Suppressive Drugs Market Overview
  • 23.2. South America Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Immuno Suppressive Drugs Market

  • 24.1. Brazil Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Immuno Suppressive Drugs Market

  • 25.1. Middle East Immuno Suppressive Drugs Market Overview
  • 25.2. Middle East Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Immuno Suppressive Drugs Market

  • 26.1. Africa Immuno Suppressive Drugs Market Overview
  • 26.2. Africa Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Immuno Suppressive Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Immuno Suppressive Drugs Market Competitive Landscape
  • 27.2. Immuno Suppressive Drugs Market Company Profiles
    • 27.2.1. Astellas Pharma
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. GlaxoSmithKline
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol Myers Squibb
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Johnson & Johnson
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Intas Pharmaceuticals Ltd.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Immuno Suppressive Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Immuno Suppressive Drugs Market

30. Immuno Suppressive Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer